Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TELEFLEX INCORPORATED

(TFX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/19/2021 11/22/2021 11/23/2021 11/24/2021 11/26/2021 Date
318.83(c) 321.24(c) 315.29(c) 317.77(c) 305.15(c) Last
698 394 448 660 596 000 360 104 304 458 Volume
-3.38% +0.76% -1.85% +0.79% -3.97% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 2 799 M - -
Net income 2021 488 M - -
Net Debt 2021 1 446 M - -
P/E ratio 2021 31,0x
Yield 2021 0,37%
Sales 2022 2 958 M - -
Net income 2022 492 M - -
Net Debt 2022 1 025 M - -
P/E ratio 2022 31,8x
Yield 2022 0,45%
Capitalization 14 295 M 14 295 M -
EV / Sales 2021 5,62x
EV / Sales 2022 5,18x
Nbr of Employees 14 000
Free-Float 97,4%
More Financials
Company
Teleflex Incorporated is a provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through four segments: Americas; Europe, Middle East and Africa (EMEA); Asia (Asia Pacific), and... 
More about the company
Ratings of Teleflex Incorporated
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about TELEFLEX INCORPORATED
11/26TELEFLEX INCORPORATED ANNOUNCES WORL : 7fr
AQ
11/18Teleflex Earns Top Spot in MedReps Best Places to Work 2022 Ranking
AQ
11/18Teleflex to Participate in the 33rd Annual Virtual Piper Sandler Healthcare Conference
AQ
11/12INSIDER SELL : Teleflex
MT
11/12TELEFLEX INCORPORATED : Ex-dividend day for
FA
11/05Teleflex Integrates Medical Education and Training with Explorer Surgical to Expand Uro..
AQ
11/04Teleflex Integrates Medical Education and Training with Explorer Surgical to Expand Uro..
AQ
11/04Teleflex Integrates Medical Education and Training with Explorer Surgical to Expand Uro..
CI
11/03Teleflex Comments on the Centers for Medicare & Medicaid Services 2022 Medicare Physici..
GL
11/03Teleflex Comments on the Centers for Medicare & Medicaid Services 2022 Medicare Physici..
GL
11/01Teleflex - The UroLift System Receives Bronze Award for Best New Branded Television Cam..
AQ
10/29JMP Securities Adjusts Price Target on Teleflex to $430 from $470, Maintains Market Out..
MT
10/29Raymond James Adjusts Teleflex's Price Target to $391 from $440, Keeps Outperform Ratin..
MT
10/29Morgan Stanley Adjusts Price Target on Teleflex to $431 From $478, Maintains Overweight..
MT
10/29UBS Cuts Price Target on Teleflex to $450 From $480, Citing Urolift Sales Estimates; Bu..
MT
More news
News in other languages on TELEFLEX INCORPORATED
10/28TELEFLEX : hausse du bénéfice ajusté et du chiffre d'affaires au troisième trimestre, révi..
10/28Teleflex déclare un dividende trimestriel, payable le 15 décembre 2021
10/28Earnings Flash (TFX) TELEFLEX INCORPORATED annonce un chiffre d'affaires de 700,3 milli..
10/28GUIDANCE : (TFX) TELEFLEX INCORPORATED prévoit une fourchette de bénéfices par action pour..
10/28Teleflex Incorporated révise ses prévisions de bénéfices pour l'année 2021
More news
Analyst Recommendations on TELEFLEX INCORPORATED
More recommendations
Chart TELEFLEX INCORPORATED
Duration : Period :
Teleflex Incorporated Technical Analysis Chart | TFX | US8793691069 | MarketScreener
Technical analysis trends TELEFLEX INCORPORATED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 305,15 $
Average target price 417,50 $
Spread / Average Target 36,8%
EPS Revisions
Managers and Directors
Liam J. Kelly Chairman, President & Chief Executive Officer
Thomas E. Powell Chief Financial Officer & Executive Vice President
Timothy F. Duffy Chief Information Officer & Vice President
Michelle Fox Chief Medical Officer & Vice President
Gwen Chapman Chief Compliance Officer & Vice President
Sector and Competitors
1st jan.Capi. (M$)
TELEFLEX INCORPORATED-25.86%14 295
ABBOTT LABORATORIES14.97%222 592
MEDTRONIC PLC-5.20%149 347
BECTON, DICKINSON AND COMPANY-2.05%69 611
HOYA CORPORATION27.96%59 428
DEXCOM, INC.60.11%57 374